Utility of the daily prospective National Institute of Mental Health Life-Chart Method (NIMH-LCM-P) ratings in clinical trials of bipolar disorder

Depression and Anxiety

Volumn 15, Issue 1, 2002, Pages 1-9

  Denicoff, Kirk D ^a   Ali, S Omar ^a   Sollinger, Ann B ^a   Smith Jackson, Earlian E ^a   Leverich, Gabriele S ^a   Post, Robert M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Bipolar disorder; Clinical global impressions scale; Global ratings; Life Chart Method

Indexed keywords

CARBAMAZEPINE; LITHIUM;

ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; MENTAL HEALTH; OUTPATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT OUTCOME;

ADULT; AGED; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0036173943     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/da.1078     Document Type: Article

References (33)

1. Recurrent brief depression: A new subtype of affective disorder
2. The emerging epidemiology of hypomania and bipolar II disorder
3. An inventory for measuring depression
4. Morbidity in treated bipolar isorder: A one-year prospective study using daily life char ratings
5. Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p)
6. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder
7. Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM™-p) for longitudinal assessment of bipolar illness
8. A diagnostic interview: The schedule for affective disorders and schizophrenia
9. The global assessment scale
10. A rating scale for depression
11. Sub syndromal symptoms in bipolar disorder: A comparison of standard and low serum levels of lithium
12. Ultra-rapid and ultradian cycling in bipolar affective illness
13. The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology
14. Life charting the course of bipolar disorder
15. Life charting of affective disorders
16. The duration, nature and recurrence rate of brief depressions
17. Use of single case analyses in off on off-on trials in affective illness: A demonstration of the efficacy of nimodipine
18. Special issues in trial design and use of placebo in bipolar illness
19. Lithium tolerance and discontinuation as pathways to refractoriness
20. Statistical approaches to trial durations in episodic affective illness
21. Graphic representation of the life course of illness in patients with affective disorder
22. A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures
23. NIMH workshop report on the treatment of bipolar disorder
24. National Institute of Mental Health Workshop Report on the treatment of bipolar disorder
25. The longitudinal course of recurrent affective illness: Life chart data from research patients at the NIMH
26. The inventory for depressive symptomatology (IDS): Preliminary findings
27. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illnes (BP): The CGI-BP
28. Life charting of the longitudinal course of recurrent affective illness
29. The Stanley Foundation Bipolar Network: Demographics and illness characteristics of the first 261 patients with bipolar disorder
30. Contingent tolerance to the anticonvulsant effects of carbamazepine: Relationship to loss of endogenous adaptive mechanisms
31. A rating scale for mania: Reliability, validity, and sensitivity